Misleading Marketing for GLP-1 Drugs

somarco

GA Medicare Expert
5000 Post Club
38,026
Atlanta
Online marketing for compounded GLP-1 drugs overstates benefits and underplays risks

Dozens of sites mislead patients by suggesting compounded obesity drugs were approved by the FDA

In Connecticut, where Medicaid has clamped down on covering GLP-1 medications for obesity, people are looking for alternatives. To make ends meet, some of Reshma Ramachandran's patients at a federally qualified health center in New Haven have turned to cash-pay, compounded versions of the drugs.

But they're sometimes confused about what they're getting. Patients who obtain compounded GLP-1s online sometimes come into visits thinking their medications are approved by the Food and Drug Administration, said Ramachandran, a physician and health services researcher at the Yale School of Medicine. "Yes, the laboratory might be registered or might be known to the FDA," she'll explain. "But the actual drugs themselves are not tested by the FDA beforehand."GLP=G


 

Latest posts

Back
Top